Across TCGA pan-cancer cohorts, PIK3IP1-DT RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated PIK3IP1-DT data layer.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher PIK3IP1-DT RNA is associated with better overall survival. In most high-consensus cancer types, elevated PIK3IP1-DT expression acts as an unfavorable survival marker, although some lineages such as LUSC and BLCA show a favorable association.
LUSC, BLCA, and KIRC are the cancer types where PIK3IP1-DT RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.